Abilify and Benlysta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Benlysta (belimumab). Common drug interactions include tremor among females.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Benlysta. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Benlysta?

Benlysta has active ingredients of belimumab. It is often used in systemic lupus erythematosus. eHealthMe is studying from 23,528 Benlysta users. Check the latest studies of Benlysta.



On Jul, 08, 2026

42 people who take Abilify and Benlysta together, and have interactions are studied.

Abilify and Benlysta drug interactions.

What are the common drug interactions of Abilify and Benlysta, by gender? *:

female:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Nausea (feeling of having an urge to vomit)
  3. Loss of consciousness
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Therapeutic response unexpected
  6. Abdominal discomfort
  7. Body temperature increased
  8. Depressed mood
  9. Dizziness
  10. Eye infection

male:

n/a

What are the common drug interactions of Abilify and Benlysta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chest pain
  2. Dry mouth
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dyspnoea (difficult or laboured respiration)
  5. Oropharyngeal pain
  6. Pericarditis (inflammation of the pericardium)
  7. Productive cough
  8. Arthralgia (joint pain)
  9. Chest discomfort
  10. Device related infection

30-39:

  1. Nausea (feeling of having an urge to vomit)
  2. Feeling hot
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Vomiting
  5. Arthralgia (joint pain)
  6. Fatigue (feeling of tiredness)
  7. Pruritus (severe itching of the skin)
  8. Abdominal discomfort
  9. Body temperature increased
  10. Depressed mood

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Diplopia (double vision)
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Infusion site pain
  7. Injection site streaking
  8. Pruritus (severe itching of the skin)
  9. Rhinorrhoea (watery mucus discharge from the nose)
  10. Vomiting

50-59:

  1. Pain in extremity
  2. Chest pain
  3. Drug ineffective
  4. Limb injury
  5. Lower limb fracture
  6. Oropharyngeal pain
  7. Pruritus (severe itching of the skin)
  8. Suicidal ideation
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Wheezing (a high-pitched whistling sound made while you breath)

60+:

  1. Cataract (clouding of the lens inside the eye)
  2. Chest pain
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Infusion related reaction
  5. Oropharyngeal pain
  6. Pruritus (severe itching of the skin)
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Wheezing (a high-pitched whistling sound made while you breath)
  9. Nightmare (unpleasant dream)
  10. Surgery

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 18 people, 42.86%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 30.95%
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Benlysta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Benlysta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benlysta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benlysta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and belimumab (the active ingredients of Abilify and Benlysta, respectively), and Abilify and Benlysta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: